Between 2021 and 2023, Tampa General Hospital achieved a notable 37% increase in deceased donor kidney transplants. During this session, we will be joined by Tampa General’s surgical director, Dr. Watkins, who will share valuable insights into the strategies that led to this success. The discussion will cover key aspects such as identifying growth opportunities, the decision to implement an in-house Hypothermic Machine Perfusion (HMP) program, and the impact of this program on transplant practices and organ utilization. Additionally, he will discuss other strategies used to expand the program and outline plans for future growth. This session offers an opportunity for other centers to leverage these insights to enhance their own transplant programs and improve outcomes.